Conference
Phase II study of cabozantinib in recurrent/metastatic endometrial cancer (EC): A study of the Princess Margaret, Chicago and California Phase II Consortia.
Authors
Dhani NC; Hirte HW; Butler MO; Lheureux S; Burnier J; Wilson MK; Jain A; Cristea MC; Welch S; Jimenez W
Volume
34
Pagination
pp. 5586-5586
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2016
DOI
10.1200/jco.2016.34.15_suppl.5586
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X